PE20121525A1 - Proteinas de union al receptor del factor 1 estimulante de colonias de macrofagos en aves - Google Patents
Proteinas de union al receptor del factor 1 estimulante de colonias de macrofagos en avesInfo
- Publication number
- PE20121525A1 PE20121525A1 PE2011002169A PE2011002169A PE20121525A1 PE 20121525 A1 PE20121525 A1 PE 20121525A1 PE 2011002169 A PE2011002169 A PE 2011002169A PE 2011002169 A PE2011002169 A PE 2011002169A PE 20121525 A1 PE20121525 A1 PE 20121525A1
- Authority
- PE
- Peru
- Prior art keywords
- avian
- seq
- macrophagus
- birds
- colonies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
SE REFIERE A UN GEN CSF1 AVIAR QUE COMPRENDE UNA SECUENCIA DE ACIDO NUCLEICO POR LO MENOS 60% IDENTICO A SEQ ID NO: 1, 2 O 4; UN GEN IL34 AVIAR QUE COMPRENDE LA SECUENCIA DE ACIDO NUCLEICO POR LO MENOS 60% IDENTICO A SEQ ID NO: 6; UNA PROTEINA SCF1 AVIAR QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS POR LO MENOS 60% IDENTICA A SEQ ID NO: 3 O 5; UNA PROTEINA IL34 AVIAR QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS POR LO MENOS 60% IDENTICA A SEQ ID NO: 6. REFERIDO ADEMAS A UN VECTOR DE EXPRESION, UNA CELULA HUESPED Y A UNA COMPOSICION INMUNOGENICA. DICHOS GENES Y PROTEINAS SON UTILES PARA MODULAR EL CRECIMIENTO AVIAR Y/O DESARROLLO DE ORGANOS Y MODULAR EL SISTEMA INMUNE AVIAR
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0910833.3A GB0910833D0 (en) | 2009-06-23 | 2009-06-23 | Avian genes |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20121525A1 true PE20121525A1 (es) | 2012-11-17 |
Family
ID=40972646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011002169A PE20121525A1 (es) | 2009-06-23 | 2010-06-22 | Proteinas de union al receptor del factor 1 estimulante de colonias de macrofagos en aves |
Country Status (10)
Country | Link |
---|---|
US (2) | US9403893B2 (es) |
EP (1) | EP2445933A1 (es) |
JP (1) | JP2012530512A (es) |
CN (1) | CN102712689A (es) |
AU (1) | AU2010264331A1 (es) |
GB (1) | GB0910833D0 (es) |
MX (1) | MX2012000252A (es) |
PE (1) | PE20121525A1 (es) |
RU (1) | RU2012102036A (es) |
WO (1) | WO2010149960A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013011021A1 (en) * | 2011-07-18 | 2013-01-24 | The University Of Melbourne | Use of c-fms antagonists |
EP3169350B1 (en) * | 2014-07-17 | 2019-01-09 | INSERM - Institut National de la Santé et de la Recherche Médicale | An isolated interleukin-34 polypeptide for use in preventing transplant rejection and treating autoimmune diseases |
MA44309A (fr) * | 2015-11-25 | 2018-10-03 | Nogra Pharma Ltd | Oligonucléotides antisens il-34 et leurs procédés d'utilisation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE240744T1 (de) | 1999-10-28 | 2003-06-15 | Hofbauer Reinhold | Verwendung von csf-1-inhibitoren |
AUPR807101A0 (en) | 2001-10-03 | 2001-10-25 | University Of Queensland, The | Csf-1 immunomodulation |
WO2008031172A1 (en) | 2006-09-15 | 2008-03-20 | Kintan Pty Ltd | Methods and compositions for promoting organ development |
-
2009
- 2009-06-23 GB GBGB0910833.3A patent/GB0910833D0/en not_active Ceased
-
2010
- 2010-06-22 AU AU2010264331A patent/AU2010264331A1/en not_active Abandoned
- 2010-06-22 JP JP2012516845A patent/JP2012530512A/ja active Pending
- 2010-06-22 WO PCT/GB2010/001221 patent/WO2010149960A1/en active Application Filing
- 2010-06-22 RU RU2012102036/10A patent/RU2012102036A/ru not_active Application Discontinuation
- 2010-06-22 MX MX2012000252A patent/MX2012000252A/es not_active Application Discontinuation
- 2010-06-22 PE PE2011002169A patent/PE20121525A1/es not_active Application Discontinuation
- 2010-06-22 CN CN2010800345401A patent/CN102712689A/zh active Pending
- 2010-06-22 US US13/380,185 patent/US9403893B2/en not_active Expired - Fee Related
- 2010-06-22 EP EP10732728A patent/EP2445933A1/en not_active Withdrawn
-
2016
- 2016-07-11 US US15/206,627 patent/US20170002051A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX2012000252A (es) | 2012-05-08 |
AU2010264331A1 (en) | 2012-02-02 |
CN102712689A (zh) | 2012-10-03 |
US20120183495A1 (en) | 2012-07-19 |
US9403893B2 (en) | 2016-08-02 |
EP2445933A1 (en) | 2012-05-02 |
GB0910833D0 (en) | 2009-08-05 |
JP2012530512A (ja) | 2012-12-06 |
WO2010149960A1 (en) | 2010-12-29 |
RU2012102036A (ru) | 2013-07-27 |
US20170002051A1 (en) | 2017-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20140867A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
CR20180492A (es) | Células t transfectadas y receptores de células t de utilidad en inmunoterapias contra el cáncer | |
NZ725079A (en) | Transgene genetic tags and methods of use | |
ES2637617T3 (es) | Método para mejorar el rendimiento de granos y promover el crecimiento de plantas | |
TR201820102T4 (tr) | Fabri hastalığı gen tedavisi. | |
NZ745324A (en) | Vaccines and vaccine components for inhibition of microbial cells | |
AR073237A1 (es) | Proteinas de bacillus thuringiensis que son toxinas activas contra hemipteros y coleopteros | |
PE20210376A1 (es) | Peptidos y combinacion de peptidos de origen no canonico para el uso en la inmunoterapia contra diferentes tipos de cancer | |
BR112016018287A2 (pt) | proteínas inseticidas e métodos para uso das mesmas | |
BRPI1010880A2 (pt) | polipeptídeos de hormônio de crescimento e métodos de fazer e usar os mesmos. | |
MX2009012609A (es) | Composiciones y metodos para producir proteinas de fusion bioactivas. | |
HK1134507A1 (en) | Peptide vaccines for cancers expressing tumor-associated antigens | |
AR070058A1 (es) | Enzima bacteriana asociada con la sintesis de ecuol | |
MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
CL2013003634A1 (es) | Complejo que comprende una proteina de fusion que comprende, un peptido viral, peptido conector, microglobulina beta 2 , peptido conector, dominios extracelulares alfa 1, 2 y 3 de mhc de clase i y un tercer peptido conector; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso | |
UY31875A (es) | Novedosos genes involucrados en la biosíntesis | |
AR047345A1 (es) | Vacuna para mejorar el crecimiento de animales a base de epitopos neutralizantes | |
NZ609903A (en) | Expression vector for high level expression of recombinant proteins | |
EA201170980A1 (ru) | Пестицидные белки и способы их применения | |
BR112017007932A2 (pt) | proteínas inseticidas e métodos para uso das mesmas | |
EA201170961A1 (ru) | Новый ген bacillus thuringiensis с активностью против lepidoptera | |
AR076349A1 (es) | Peptido auxiliar del antigeno del cancer | |
AR071232A1 (es) | Proteina hibrida usada como vacuna contra toxinas shiga de e. coli | |
PE20091355A1 (es) | Paramixovirus oncoliticos atenuados que codifican citoquinas de aves | |
AR107463A1 (es) | Gen de bacillus thuringiensis con actividad contra el orden lepidoptera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |